RADX
Radiopharm Theranostics LtdCompany with tickers: RADX, RDPTF
CIK
1949257
CUSIP
75041J101
Shares Outstanding
7,883,165
13F Activity (30d)
5 filings
5 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-18 | Voliotis Dimitris |
SVP, Clinical Development | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 6,985,292 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Larkin Hester Denise |
Director | Other | 0 |
| 2026-03-18 | Larkin Hester Denise |
Director | Other | 0 |
| 2026-03-18 | Voliotis Dimitris |
SVP, Clinical Development | Other | 0 |
| 2026-03-18 | Larkin Hester Denise |
Director | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 93,571,428 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 53,900,000 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Larkin Hester Denise |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Voliotis Dimitris |
SVP, Clinical Development | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Goodwin Bruce Michael |
Director | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 22,679,986 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Donnelly Noel |
Chief Financial Officer | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Larkin Hester Denise |
Director | Other | 644,247 |
| 2026-03-18 | Laurita Aaron James |
Chief Financial Officer | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Laurita Aaron James |
Chief Financial Officer | Other | 26,357 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 3,000,000 |
| 2026-03-18 | HOPPER PAUL |
Director | Other | 0 |
| 2026-03-18 | Turner Ian Lawrence |
Director | Other | 0 |
| 2026-03-18 | Canevari Riccardo |
Director, Managing Director and CEO | Other | 0 |
| 2026-03-18 | Donnelly Noel |
Chief Financial Officer | Other | 0 |
Showing 1–50 of 59 transactions